Premier Biomedical, Inc. (BIEI)

OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
Mar 9, 2026, 1:52 PM EST
-33.33%
Market Cap 559.99K
Revenue (ttm) 14.28K
Net Income (ttm) -374.47K
Shares Out 1.40B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 7,389,327
Open 0.0004
Previous Close 0.0004
Day's Range 0.0004 - 0.0004
52-Week Range 0.0003 - 0.0017
Beta 0.06
RSI 36.00
Earnings Date n/a

About Premier Biomedical

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more]

Sector Healthcare
Founded 2010
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol BIEI
Full Company Profile

Financial Performance

In 2019, Premier Biomedical's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.

Financial Statements

News

There is no news available yet.